Savara (SVRA) Non Operating Interest Expenses (2011 - 2018)
Powered by 
Analysis
Savara (SVRA) Non Operating Interest Expenses (2011 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Savara | 1.36 Bn | 1.36 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 113,000.00 |
| Mar 31, 2018 | 104,000.00 |
| Dec 31, 2017 | 123,000.00 |
| Sep 30, 2017 | 277,000.00 |
| Jun 30, 2017 | 516,000.00 |
| Mar 31, 2017 | 245,000.00 |
| Dec 31, 2016 | 245,000.00 |
| Sep 30, 2016 | 190,000.00 |
| Jun 30, 2016 | 7,000.00 |
| Mar 31, 2016 | 519,000.00 |
| Dec 31, 2015 | 2.48 Mn |
| Sep 30, 2015 | 101,000.00 |
| Jun 30, 2015 | 1,000.00 |
| Mar 31, 2012 | 10,710.00 |
| Dec 31, 2011 | 10,738.00 |
| Sep 30, 2011 | 272.00 |